The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial

Margaret A. Fischl, Douglas D. Richman, Nellie Hansen, Ann C. Collier, John T. Carey, Michael F. Para, W. David Hardy, Raphael Dolin, William G. Powderly, J. Davis Allan, Brian Wong, Thomas C. Merigan, Vincent J. McAuliffe, Newton E. Hyslop, Frank S. Rhame, Henry H. Balfour, Stephen A. Spector, Paul Volberding, Carla Pettinelli, James Anderson

Research output: Contribution to journalArticlepeer-review

612 Scopus citations

Fingerprint

Dive into the research topics of 'The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences